NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Cancer Gene Therapy



Institute for Digestive Medicine details research in cancer gene therapy



October 7th, 2008

A report, 'AAV-HGFK1 and Ad-p53 cocktail therapy prolongs survival of mice with colon cancer,' is newly published data in Molecular Cancer Therapeutics. "This study tried to evaluate the application of a novel cancer gene therapy using recombinant adeno-associated virus (AAV) carrying the kringle 1 domain of human hepatocyte growth factor (AAV-HGFK1) in combination with recombinant adenovirus carrying p53 gene (Ad-p53). BALB/c and nude mice models of colon cancer were established and the mice were treated with AAV-HGFK1 alone or in combination with Ad-p53," researchers in Taiwan report.

"Combination of AAV-HGFK1 and Ad-p53 significantly prolonged the survival of...


Source: Cancer Weekly (2008-10-07)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login